The nasal mycobiome of individuals with allergic rhinitis and asthma differs from that of healthy controls in composition, structure and function
Open Access
- 17 December 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 15, 1464257
Abstract
Allergic rhinitis (AR) and asthma (AS) are two of the most common chronic respiratory diseases and a major public health concern. Multiple studies have demonstrated the role of the nasal bacteriome in AR and AS, but little is known about the airway mycobiome and its potential association to airway inflammatory diseases. Here we used the internal transcriber spacers (ITS) 1 and 2 and high-throughput sequencing to characterize the nasal mycobiome of 339 individuals with AR, AR with asthma (ARAS), AS and healthy controls (CT). Seven to ten of the 14 most abundant fungal genera (Malassezia, Alternaria, Cladosporium, Penicillium, Wallemia, Rhodotorula, Sporobolomyces, Naganishia, Vishniacozyma, and Filobasidium) in the nasal cavity differed significantly (p ≤ 0.049) between AS, AR or ARAS, and CT. However, none of the same genera varied significantly between the three respiratory disease groups. The nasal mycobiomes of AR and ARAS patients showed the highest intra-group diversity, while CT showed the lowest. Alpha-diversity indices of microbial richness and evenness only varied significantly (p ≤ 0.024) between AR or ARAS and CT, while all disease groups showed significant differences (p ≤ 0.0004) in microbial structure (i.e., beta-diversity indices) when compared to CT samples. Thirty metabolic pathways (PICRUSt2) were differentially abundant (Wald’s test) between AR or ARAS and CT patients, but only three of them associated with 5-aminoimidazole ribonucleotide (AIR) biosynthesis were over abundant (log2 Fold Change >0.75) in the ARAS group. AIR has been associated to fungal pathogenesis in plants. Spiec-Easi fungal networks varied among groups, but AR and ARAS showed more similar interactions among their members than with those in the CT mycobiome; this suggests chronic respiratory allergic diseases may disrupt fungal connectivity in the nasal cavity. This study contributes valuable fungal data and results to understand the relationships between the nasal mycobiome and allergy-related conditions. It demonstrates for the first time that the nasal mycobiota varies during health and allergic rhinitis (with and without comorbid asthma) and reveals specific taxa, metabolic pathways and fungal interactions that may relate to chronic airway disease.Keywords
Funding Information
- European Regional Development Fund
- Fundação para a Ciência e a Tecnologia (PTDC/ASP-PES/27953/2017, POCI-01-0145-FEDER-027953)
- European Social Fund Plus (IF/00764/2013)
- Ministério da Educação e Ciência
This publication has 119 references indexed in Scilit:
- The Fungal Microbiome of the Upper Airway Is Associated With Future Loss of Asthma Control and Exacerbation Among Children With AsthmaChest, 2023
- Worldwide prevalence of rhinitis in adults: A review of definitions and temporal evolutionClinical and Translational Allergy, 2022
- Comparing the nasal bacterial microbiome diversity of allergic rhinitis, chronic rhinosinusitis and control subjectsEuropean Archives of Oto-Rhino-Laryngology, 2020
- A Comparison of the Bacterial Nasal Microbiome in Allergic Rhinitis Patients Before and After ImmunotherapyThe Laryngoscope, 2020
- Dysbiosis of the gut and lung microbiome has a role in asthmaSeminars in Immunopathology, 2020
- Impact of nasopharyngeal microbiota on the development of respiratory tract diseasesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2017
- Mapping and comparing bacterial microbiota in the sinonasal cavity of healthy, allergic rhinitis, and chronic rhinosinusitis subjectsInternational Forum of Allergy & Rhinology, 2017
- Asthma: definitions and pathophysiologyInternational Forum of Allergy & Rhinology, 2015
- The Infant Nasopharyngeal Microbiome Impacts Severity of Lower Respiratory Infection and Risk of Asthma DevelopmentCell Host & Microbe, 2015
- Defining a Healthy Human Gut Microbiome: Current Concepts, Future Directions, and Clinical ApplicationsCell Host & Microbe, 2012